These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38981401)

  • 21. Neuroprotective effects of resveratrol in an MPTP mouse model of Parkinson's-like disease: possible role of SOCS-1 in reducing pro-inflammatory responses.
    Lofrumento DD; Nicolardi G; Cianciulli A; De Nuccio F; La Pesa V; Carofiglio V; Dragone T; Calvello R; Panaro MA
    Innate Immun; 2014 Apr; 20(3):249-60. PubMed ID: 23764428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
    Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK
    Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective effects of tetramethylpyrazine against dopaminergic neuron injury in a rat model of Parkinson's disease induced by MPTP.
    Lu C; Zhang J; Shi X; Miao S; Bi L; Zhang S; Yang Q; Zhou X; Zhang M; Xie Y; Miao Q; Wang S
    Int J Biol Sci; 2014; 10(4):350-7. PubMed ID: 24719552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective Effects of Ursodeoxycholic Acid Against Oxidative Stress and Neuroinflammation Through Mitogen-Activated Protein Kinases Pathway in MPTP-Induced Parkinson Disease.
    Jiang C; Shen D; Li K; Wang H; Sang W; Qi H
    Clin Neuropharmacol; 2022 Nov-Dec 01; 45(6):168-174. PubMed ID: 36383915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rosmarinic acid protects against MPTP-induced toxicity and inhibits iron-induced α-synuclein aggregation.
    Qu L; Xu H; Jia W; Jiang H; Xie J
    Neuropharmacology; 2019 Jan; 144():291-300. PubMed ID: 30342981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 4-Aminopyridine Protects Nigral Dopaminergic Neurons in the MPTP Mouse Model of Parkinson's Disease.
    Shi L; Jia L; Wang Y; Xiu M; Xie J
    Neurochem Res; 2023 Jun; 48(6):1707-1715. PubMed ID: 36602724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (+)-Borneol Protects Dopaminergic Neuronal Loss in Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Parkinson's Disease Mice: A Study of Dopamine Level using In Vivo Brain Microdialysis.
    Ding L; Wang L; Yang J; Jiang C; Sun X; Huang H; Zhan X; Liu F; Zhang Q
    ACS Chem Neurosci; 2024 Jun; 15(11):2308-2321. PubMed ID: 38747405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
    Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
    Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson's disease.
    Ghosh A; Kanthasamy A; Joseph J; Anantharam V; Srivastava P; Dranka BP; Kalyanaraman B; Kanthasamy AG
    J Neuroinflammation; 2012 Oct; 9():241. PubMed ID: 23092448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease.
    Bahdoudi S; Ghouili I; Hmiden M; do Rego JL; Lefranc B; Leprince J; Chuquet J; do Rego JC; Marcher AB; Mandrup S; Vaudry H; Tonon MC; Amri M; Masmoudi-Kouki O; Vaudry D
    Cell Mol Life Sci; 2018 Jun; 75(11):2075-2091. PubMed ID: 29264673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel iron (II) preferring dopamine agonist chelator D-607 significantly suppresses α-syn- and MPTP-induced toxicities in vivo.
    Das B; Rajagopalan S; Joshi GS; Xu L; Luo D; Andersen JK; Todi SV; Dutta AK
    Neuropharmacology; 2017 Sep; 123():88-99. PubMed ID: 28533164
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced Nicotinamide Adenine Dinucleotide Phosphate Inhibits MPTP-Induced Neuroinflammation and Neurotoxicity.
    Zhou Y; Wu J; Sheng R; Li M; Wang Y; Han R; Han F; Chen Z; Qin ZH
    Neuroscience; 2018 Nov; 391():140-153. PubMed ID: 30195055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
    Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
    J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PPARß/δ agonist alleviates NLRP3 inflammasome-mediated neuroinflammation in the MPTP mouse model of Parkinson's disease.
    Chen L; Xue L; Zheng J; Tian X; Zhang Y; Tong Q
    Behav Brain Res; 2019 Jan; 356():483-489. PubMed ID: 29885849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D Treatment Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in an Animal Model of Parkinson's Disease, Shifting M1 to M2 Microglia Responses.
    Calvello R; Cianciulli A; Nicolardi G; De Nuccio F; Giannotti L; Salvatore R; Porro C; Trotta T; Panaro MA; Lofrumento DD
    J Neuroimmune Pharmacol; 2017 Jun; 12(2):327-339. PubMed ID: 27987058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective effects of MHY908, a PPAR α/γ dual agonist, in a MPTP-induced Parkinson's disease model.
    Lee Y; Cho JH; Lee S; Lee W; Chang SC; Chung HY; Moon HR; Lee J
    Brain Res; 2019 Feb; 1704():47-58. PubMed ID: 30273550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through PI3K/Akt and ERK signaling pathways.
    Cao Q; Qin L; Huang F; Wang X; Yang L; Shi H; Wu H; Zhang B; Chen Z; Wu X
    Toxicol Appl Pharmacol; 2017 Mar; 319():80-90. PubMed ID: 28185818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potential neuroprotective effect of t-butylhydroquinone against neurotoxicity-induced by 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-methyl-MPTP) in mice.
    Abdel-Wahab MH
    J Biochem Mol Toxicol; 2005; 19(1):32-41. PubMed ID: 15736157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation.
    Chung YC; Kim SR; Park JY; Chung ES; Park KW; Won SY; Bok E; Jin M; Park ES; Yoon SH; Ko HW; Kim YS; Jin BK
    Neuropharmacology; 2011 May; 60(6):963-74. PubMed ID: 21288472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folic Acid Rescues Dopaminergic Neurons in MPTP-Induced Mice by Inhibiting the NLRP3 Inflammasome and Ameliorating Mitochondrial Impairment.
    Jia Y; Li J; Wang Y; Ma Y; Chen L; Zhang H; Xue M; Liang H
    J Agric Food Chem; 2024 Mar; 72(11):5734-5745. PubMed ID: 38453725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.